Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

0
Player Avatar pchop123 (79.56) Submitted: 11/30/2012 10:58:36 AM : Underperform Start Price: $1.85 ACUR Score: +21.92

No confidence in them at this point

Featured Broker Partners


Advertisement